These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23750677)

  • 21. Anesthetic management for implantation of a treatment device: the Rheos Baroreflex Hypertensive Therapy System.
    Thai NN
    AANA J; 2012 Feb; 80(1):18-24. PubMed ID: 22474800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathophysiological basis of carotid baroreceptor stimulation for the treatment of resistant hypertension.
    Lovic D; Manolis AJ; Lovic B; Stojanov V; Lovic M; Pittaras A; Jakovljevic B
    Curr Vasc Pharmacol; 2014 Jan; 12(1):16-22. PubMed ID: 23905596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baroreflex stimulation in antihypertensive treatment.
    Taylor JG; Bisognano JD
    Curr Hypertens Rep; 2010 Jun; 12(3):176-81. PubMed ID: 20424952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baropacing as a new option for treatment of resistant hypertension.
    Alnima T; de Leeuw PW; Kroon AA
    Eur J Pharmacol; 2015 Sep; 763(Pt A):23-7. PubMed ID: 25987419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic characteristics of carotid sinus pressure-nerve activity transduction in rabbits.
    Kawada T; Yamamoto K; Kamiya A; Ariumi H; Michikami D; Shishido T; Sunagawa K; Sugimachi M
    Jpn J Physiol; 2005 Jun; 55(3):157-63. PubMed ID: 16079025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.
    Doumas M; Guo D; Papademetriou V
    Expert Opin Ther Targets; 2009 Apr; 13(4):413-25. PubMed ID: 19335064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closed-loop estimation of the open-loop carotid sinus baroreflex transfer function for the use of animal experiments in space.
    Kawada T; Sato T; Shishido T; Sugimachi M; Sunagawa K
    J Gravit Physiol; 2000 Jul; 7(2):P137-8. PubMed ID: 12697495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Tordoir JH; Scheffers I; Schmidli J; Savolainen H; Liebeskind U; Hansky B; Herold U; Irwin E; Kroon AA; de Leeuw P; Peters TK; Kieval R; Cody R
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):414-21. PubMed ID: 17227715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.
    Illig KA; Levy M; Sanchez L; Trachiotis GD; Shanley C; Irwin E; Pertile T; Kieval R; Cody R
    J Vasc Surg; 2006 Dec; 44(6):1213-1218. PubMed ID: 17145423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL; Nadim MK; Haller H; Lovett EG; Schafer JE; Bisognano JD
    J Am Soc Hypertens; 2012; 6(2):152-8. PubMed ID: 22341199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carotid Sinus/Nerve Stimulation for Treatment of Resistant Hypertension and Heart Failure.
    Yin D; Slavin KV
    Prog Neurol Surg; 2015; 29():83-93. PubMed ID: 26394178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension.
    Gassler JP; Lynch PS; Bisognano JD
    Heart; 2012 Dec; 98(23):1689-92. PubMed ID: 22895643
    [No Abstract]   [Full Text] [Related]  

  • 34. Insight into human baroreceptor function using multiple indices of neural activity.
    Baily RG; Sinoway LI
    Heart Fail; 1990; 6(1):33-41. PubMed ID: 11539207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baroreflex activation therapy systems: current status and future prospects.
    Seravalle G; Dell'Oro R; Grassi G
    Expert Rev Med Devices; 2019 Dec; 16(12):1025-1033. PubMed ID: 31774336
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of baroreflex activation therapy for the treatment of resistant hypertension.
    Briasoulis A; Bakris G
    EuroIntervention; 2013 May; 9 Suppl R():R136-9. PubMed ID: 23732146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baroreceptor Stimulation for Resistant Hypertension.
    Yoruk A; Bisognano JD; Gassler JP
    Am J Hypertens; 2016 Dec; 29(12):1319-1324. PubMed ID: 27444637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic activation in resistant hypertension: theory and therapy.
    Oliva RV; Bakris GL
    Semin Nephrol; 2014; 34(5):550-9. PubMed ID: 25416664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of emetic response by carotid baro- and chemoreceptor activations.
    Uchino M; Kuwahara M; Ebukuro S; Tsubone H
    Auton Neurosci; 2006 Jul; 128(1-2):25-36. PubMed ID: 16490404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point:counterpoint: respiratory sinus arrhythmia is due to a central mechanism vs. respiratory sinus arrhythmia is due to the baroreflex mechanism.
    Eckberg DL
    J Appl Physiol (1985); 2009 May; 106(5):1740-2; discussion 1744. PubMed ID: 18719228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.